Consultation opens on population screening for cytomegalovirus
The UK NSC has opened a consultation on evidence relating to antenatal and newborn screening for cytomegalovirus (CMV).
Cristina Visintin
Dr Cristina Visintin is the Research Lead for the UK NSC Research Methodology Group within the UK NSC Secretariat. She has a background in medicinal chemistry with over 15 years’ experience in managing projects that focus on evidence aggregation for decision-making for clinical guidelines and screening policies.
UK NSC is reviewing the latest evidence for additional screening based on breast density
The UK NSC this summer plans to share its review of the latest evidence on whether women with dense breasts should be offered additional breast screening imaging tests.